Better Therapeutics (BTTX) Insider Trading & Ownership $0.0001 0.00 (0.00%) (As of 12/20/2024 02:47 PM ET) Add Compare Share Share Insider Trades Stock AnalysisChartCompetitorsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsTrends Better Therapeutics (NASDAQ:BTTX) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage51.40%Number OfInsiders Buying(Last 3 Years)8Amount OfInsider Buying(Last 3 Years)$1.99 MNumber OfInsiders Selling(Last 3 Years)0 Get BTTX Insider Trade Alerts Want to know when executives and insiders are buying or selling Better Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address BTTX Insider Buying and Selling by Quarter Ad Brownstone ResearchMedia Humiliated: Demo of Elon’s Tech Proves They’re WrongElon Musk believes his new AI product will be worth an incredible $9 trillion. But the mainstream media is not buying it.Click here to watch this demo and decide for yourself. Better Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/27/2023Andrew J ArmaninoDirectorBuy274,010$0.73$200,027.30 7/27/2023David P PerryChairmanBuy1,233,045$0.73$900,122.85 7/27/2023Frank KarbeCEOBuy137,005$0.73$100,013.65 7/27/2023Mark A BermanInsiderBuy54,802$0.73$40,005.46 5/16/2023Elder GrangerDirectorBuy600$0.87$522.00 4/10/2023Frank KarbeInsiderBuy242,424$0.82$198,787.68 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 4/10/2023Geoffrey M ParkerDirectorBuy303,030$0.82$248,484.60 9/15/2022Frank KarbeInsiderBuy50,000$2.09$104,500.00 9/12/2022Mark HeinenInsiderBuy23,868$1.94$46,303.92 6/24/2022Mark HeinenInsiderBuy2,281$1.75$3,991.75 6/13/2022Geoffrey M ParkerDirectorBuy25,000$1.45$36,250.00 6/10/2022Mark HeinenInsiderBuy5,000$1.56$7,800.00 3/31/2022Kevin J AppelbaumCEOBuy2,500$1.97$4,925.00 3/31/2022Mark HeinenInsiderBuy5,000$1.98$9,900.00 3/29/2022Andrew J ArmaninoDirectorBuy40,000$2.14$85,600.00 (Data available from 1/1/2013 forward) BTTX Insider Trading Activity - Frequently Asked Questions Who is on Better Therapeutics's Insider Roster? The list of insiders at Better Therapeutics includes Andrew J Armanino, David P Perry, Elder Granger, Frank Karbe, Geoffrey M Parker, Kevin J Appelbaum, Mark A Berman, and Mark Heinen. Learn more on insiders at BTTX. What percentage of Better Therapeutics stock is owned by insiders? 51.40% of Better Therapeutics stock is owned by insiders. Learn more on BTTX's insider holdings. Which Better Therapeutics insiders have been buying company stock? The following insiders have purchased BTTX shares in the last 24 months: Andrew J Armanino ($200,027.30), David P Perry ($900,122.85), Elder Granger ($522.00), Frank Karbe ($298,801.33), Geoffrey M Parker ($248,484.60), and Mark A Berman ($40,005.46). How much insider buying is happening at Better Therapeutics? Insiders have purchased a total of 2,244,916 BTTX shares in the last 24 months for a total of $1,687,963.54 bought. Better Therapeutics Key ExecutivesMr. David P. Perry M.B.A. (Age 56)Co-Founder & Executive Chairman Compensation: $260kMr. Frank L. Karbe (Age 56)CEO, Interim CFO, President & Director Compensation: $533.37kDr. Mark A. Berman M.D. (Age 48)Chief Medical Officer Compensation: $573.75kMs. Kristin Wynholds (Age 51)Chief Product Officer Compensation: $519.07kMr. Andres CamachoSenior VP of Technology & Head of EngineeringMs. Angela WillisSenior Vice President of Market AccessMs. Jessica MengChief Commercial OfficerLeslie MillerController More Insider Trading Tools from MarketBeat Related Companies AONC Insider Trades LFMDP Insider Trades TOIIW Insider Trades NTRA Insider Trades FMS Insider Trades HIMS Insider Trades GH Insider Trades OPCH Insider Trades SHC Insider Trades VCYT Insider Trades Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:BTTX) was last updated on 12/22/2024 by MarketBeat.com Staff From Our PartnersWhy Buffett, Griffin and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredThis Crypto Is Set to Explode in DecemberIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredAI breakthrough about to upend industryEveryone is talking about AI right now. The talk has been endless ever since ChatGPT was released to the m...Porter & Company | SponsoredYour bank is lying to you.You might think you have your money in a high-yield savings account, but do you really? The national average A...MyBankTracker | SponsoredMUST SEE: The most important video in the world right now?If you have a significant amount of money in the stock market right now — or if you're sitting on the sideline...InvestorPlace | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Starting with what I call Exec. Order 001. It’s a bombshell law that I believe Trump will sign within minut...Banyan Hill Publishing | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Better Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Better Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
